Jun 20, 2019 | Information, Latest News, Retinitis Pigmentosa, Stem cells
VANCOUVER, British Columbia — Human retinal progenitor cell therapy from ReNeuron Group is showing positive preliminary results in the company’s ongoing phase 1/2a clinical trial involving patients with retinitis pigmentosa. ReNeuron chief medical officer Richard...
Jan 3, 2019 | age-related macular degeneration (ARMD), Information, Latest News, Retinitis Pigmentosa
A Space Experiment That Could One Day Cure Blindness By PATRICK SKAHILL A powerful purple protein that could help cure certain types of blindness has made its way from a tiny Farmington laboratory all the way up to the International Space Station. That protein is a...
Jun 26, 2018 | age-related macular degeneration (ARMD), AMD Research, Retinitis Pigmentosa
UCI researcher receives CIRM funding for stem cell-based retina therapy to treat blindness UNIVERSITY OF CALIFORNIA – IRVINE University of California, Irvine stem cell researcher Magdalene J. Seiler, PhD, has received a $4.8 million grant from the California...
Recent Comments